Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Nohra Guy P
Relationship:   Director
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   10,292,949    

Indirect Shares

   31,541,253      
Direct Value   $215,092,687    

Indirect Value

   $215,434,658      
Total Shares   41,834,202      
Total Value   $430,527,345      


Rigel Pharmaceuticals Inc $11,703 Crucell Nv $0 Ellie Mae Inc $151,292,653 Aerie Pharmaceuticals Inc $55,145,510 Evofem Biosciences Inc $1,339,776 aTyr Pharma Inc $651,483 Sutro Biopharma Inc $6,651,561 Bioventus Inc. $0 Rigel Pharmaceuticals Inc $11,703 Crucell Nv $0 Ellie Mae Inc $151,292,653 Aerie Pharmaceuticals Inc $55,145,510 Evofem Biosciences Inc $1,339,776 aTyr Pharma Inc $651,483 Sutro Biopharma Inc $6,651,561 Bioventus Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 31.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            AVADEL Pharmaceuticals Plc AVDL N/A 2003-10-02 0 2003-10-02 6,443    Premium*  
            Rigel Pharmaceuticals Inc RIGL N/A 2004-08-20 9,593 2004-08-20 29,715    Premium*  
            Renovis Inc RNVS Director 2004-02-10 0 2004-02-10 42,240    Premium*  
            Crucell Nv CRXLY N/A 2004-05-25 6,436 2004-05-25 0    Premium*  
            Icagen Inc ICGN 10% Owner 2005-02-08 0 2005-02-08 2,135,003    Premium*  
            Cutera Inc CUTR Director 2005-08-15 0 2005-08-15 0    Premium*  
            Neurogesx Inc NGSX 10% Owner 2007-05-07 0 2007-05-07 1,735,673    Premium*  
            Acelrx Pharmaceuticals Inc ACRX Director 2011-02-16 0 2013-09-20 2,507,974    Premium*  
            Ellie Mae Inc ELLI 10% Owner 2011-04-20 1,528,363 2011-04-20 1,524,804    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 2013-07-01 0 2014-10-21 2,552,189    Premium*  
            Aerie Pharmaceuticals Inc AERI 10% Owner 2014-05-22 3,616,099 2013-10-30 0    Premium*  
            Trevena Inc TRVN 10% Owner 2014-02-05 0 2014-12-10 4,390,262    Premium*  
            Zs Pharma, Inc. ZSPH Director 2015-12-17 0 2014-06-23 3,230,090    Premium*  
            Evofem Biosciences Inc EVFM Former 10% Owner 2015-12-30 1,339,776 2014-11-25 2,595,257    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director 2015-04-14 0 2015-04-14 4,343,550    Premium*  
            aTyr Pharma Inc LIFE 10% Owner 2015-05-12 1,778,064 2015-05-12 0    Premium*  
            Allakos Inc. ALLK 10% Owner 2021-03-04 0 2021-03-04 6,448,053    Premium*  
            Sutro Biopharma Inc STRO 10% Owner 2018-10-01 1,944,901 2018-10-01 0    Premium*  
            Bioventus Inc. BVS Director 2023-08-16 69,717 2023-08-16 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BVS Bioventus Inc. Director   –       •      –    2023-08-16 4/A D $0.00 $0 I/I (2,604,264) 0 0 -
BVS Bioventus Inc. Director   –       •      –    2023-08-16 4 A $0.00 $0 D/D 41,369 69,717 0 -
BVS Bioventus Inc. Director   –       •      –    2023-06-06 4 OE $0.00 $0 D/D 16,648 28,348 0 -
BVS Bioventus Inc. Director   –       •      –    2022-04-01 4 OE $0.00 $0 D/D 2,700 11,700 0 -
BVS Bioventus Inc. Director   –       •      –    2022-02-11 4 OE $0.00 $0 D/D 9,000 9,000 0 -
ALLK Allakos Inc. 10% Owner   –       –       •   2021-03-04 4 S $108.89 $2,876,742 D/D (25,768) 0 0 %
BVS Bioventus Inc. Director   –       •      –    2021-02-11 3/A IO $0.00 $0 I/I 0 2,604,264 -
ALLK Allakos Inc. 10% Owner   –       –       •   2020-06-17 4 S $75.23 $581,693 D/D (7,692) 0 0 %
STRO Sutro Biopharma Inc 10% Owner   –       –       •   2018-10-01 4 A $0.00 $0 D/D 1,944,901 1,944,901 0 -
ALLK Allakos Inc. 10% Owner   –       –       •   2018-07-23 4 B $18.00 $4,500,000 I/I 250,000 11,519,200 1.5 -
ALLK Allakos Inc. 10% Owner   –       –       •   2018-07-23 4 A $0.00 $0 I/I 11,269,200 11,269,200 0 -
EVFM Evofem Biosciences Inc Former 10% Owner   –       –      –    2015-12-30 4 S $1.44 $360,000 D/D (250,000) 1,339,776 0 -
EVFM Evofem Biosciences Inc Former 10% Owner   –       –      –    2015-12-29 4 S $1.53 $755,291 D/D (493,654) 1,589,776 0 -
EVFM Evofem Biosciences Inc Former 10% Owner   –       –      –    2015-12-28 4 S $1.59 $86,389 D/D (54,333) 2,083,430 0 -
ZSPH Zs Pharma, Inc. Director   –       •      –    2015-12-17 4 D $90.00 $90,000 D/D (1,000) 0 0 -
EVFM Evofem Biosciences Inc 10% Owner   –       –       •   2015-12-15 4 S $1.44 $762,136 D/D (529,261) 2,137,763 0 -
ZSPH Zs Pharma, Inc. Director   –       •       •   2015-06-08 4 S $57.53 $644,336 D/D (11,200) 2,646,643 0 -
ZSPH Zs Pharma, Inc. Director   –       •       •   2015-06-05 4 S $57.88 $9,505,459 D/D (164,227) 2,657,843 0 -
ZSPH Zs Pharma, Inc. Director   –       •       •   2015-06-04 4 S $57.21 $5,082,278 D/D (88,408) 2,822,070 0 -
ZSPH Zs Pharma, Inc. Director   –       •       •   2015-06-03 4 S $56.60 $1,312,497 D/D (23,189) 2,910,478 0 -
ZSPH Zs Pharma, Inc. Director   –       •       •   2015-06-02 4 S $56.77 $4,788,095 D/D (84,342) 2,933,667 0 -
ZSPH Zs Pharma, Inc. Director   –       •       •   2015-06-01 4 S $58.00 $4,206,160 D/D (72,520) 3,018,009 0 -
ZSPH Zs Pharma, Inc. Director   –       •       •   2015-05-29 4 S $58.63 $8,198,039 D/D (139,561) 3,090,529 0 -
LIFE aTyr Pharma Inc 10% Owner   –       –       •   2015-05-12 4 A $0.00 $0 D/D 1,778,064 1,778,064 0 -
KALV Kalvista Pharmaceuticals ... Director   –       •      –    2015-04-14 4 B $5.00 $4,387,500 I/I 877,500 4,343,550 2.1 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us